In this episode:

• Healthcare professionals are pivotal in assessing the risk of patients having metabolic associated fatty liver disease (MAFLD) and its link with metabolic disease progression
• What indicators to look out for, given fatty liver can occur in the absence of raised transaminases
• The importance of using calculators like the Fib4, when to ask a patient to have a fibrous scan, interpretation of results and when to refer to a specialist
• Consensus guidelines on MAFLD expected later in 2024, and what learning courses to consider

Expert: Prof Simone Strasser, Hepatologist

Host: Dr David Lim, GP and Medical Educator

Total time: 25 mins

Recommended resources:

• Liver Foundation | Fatty liver disease
• Liver Foundation | GP information
• InSight | Rising burden of metabolic-associated fatty liver disease
• Recommendations for the assessment of metabolic dysfunction-associated fatty liver disease (MAFLD) in primary care: A consensus statement | GESA